advertisement
Abstract #3602 Published in IGR 4-2
Retrobulbar chlorpromazine injections for the management of blind and seeing painful eyes
Chen TC; Ahn Yuen SJ; Sangalang MA; Fernando RE; Leuenberger EUJournal of Glaucoma 2002; 11: 209-213
PURPOSE: To report the efficacy of primary retrobulbar chlorpromazine injections for the management of blind and seeing painful eyes. PATIENTS AND METHODS: Retrospective case series from three university hospitals was done. Twenty eyes of 20 patients with at least three months of follow-up are reported. Ten of these 20 eyes did not receive any other ophthalmic medications either two weeks before chlorpromazine injection or at any time point after injection. Treatment was considered successful if pain control lasted for at least three months, without the need for reinjection or enucleation. RESULTS: Sixteen of 20 (80.0%) eyes achieved successful pain control. There were no permanent complications in any patient. CONCLUSIONS: Retrobulbar chlorpromazine appears to be safe and effective for the management of pain in blind eyes.
Dr. T.C. Chen, Glaucoma Service, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114, USA. teresa_chen@meei.harvard.edu
Classification:
11.20 Other (Part of: 11 Medical treatment)